Physician profile
John Eric Ashton
NPI 1770785503
$1,013.86
in general payments reported to CMS, 2019-2025
22 companies · $595 in 2025
The $595 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.72 · 2022: $49.53 · 2023: $85.95 · 2024: $263 · 2025: $595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $944.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $188.11 | 2022-2025 | Wavewriter Alpha Prime 16, Spectra Wavewriter, General - Therapies |
| Otsuka America Pharmaceutical, INC. | $165.05 | 2025 | Rexulti |
| Medtronic, INC. | $104.10 | 2023-2025 | Intellis Adaptivestim |
| Bayer Healthcare Pharmaceuticals INC. | $96.20 | 2023-2025 | |
| Lilly USA, LLC | $49.12 | 2025 | Jardiance |
| Noven Therapeutics, LLC | $46.48 | 2024 | Xelstrym |
| Abbott Laboratories | $37.97 | 2022-2023 | Proclaim |
| Antares Pharma, INC. | $32.20 | 2024-2025 | Xyosted |
| Novo Nordisk INC | $31.31 | 2025 | Wegovy, Rybelsus, Ozempic |
| Daiichi Sankyo INC. | $29.84 | 2024 | Injectafer |
| Exact Sciences Corporation | $29.38 | 2025 | Cologuard Collection Kit |
| Recordati_rare_diseases_inc. | $26.54 | 2025 | Isturisa |
| Ascensia Diabetes Care US INC. | $24.37 | 2024 | |
| Stryker Corporation | $21.93 | 2025 | Clottriever Bold Catheter |
| Axsome Therapeutics, INC. | $21.14 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $19.75 | 2025 | Gemtesa |
| Convatec INC. | $19.72 | 2021 | |
| Inari Medical, INC. | $14.84 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astrazeneca Pharmaceuticals LP | $14.38 | 2023 | Farxiga |
| Abbvie INC. | $14.30 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.68 | 2025 | Xifaxan |
| Cvrx, INC. | $13.45 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ashton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.